Investor · TACOMA, WA
Chris Fibiger
Open Chris in the network graph →Capital
$64.4M
across filings
Active
Dec 2022
to Dec 2025
Most-connected co-filers (61)
Dan Adams · Boston, MA8 sharedMichael Goguen · NEW YORK, NY7 sharedUnicorns Capital LLC · Dover, DE7 sharedZachary J. Epstein · Mountain View, CA5 sharedTwo Bear Capital Fund GP I, LLC · WHITEFISH, MT5 sharedParas P. Malde · Grand Cayman, Cayman Islands4 sharedChristy Shelton · Greensboro, NC4 sharedBrian Shin · Reno, NV3 sharedCoy Wells · Greensboro, NC3 sharedNoel Hall · Westport, CT3 sharedAnil Hingorani · Mountain Lakes, NJ3 sharedShawn C. Baker · Austin, TX3 sharedStephen Lucey · Greensboro, NC3 sharedDaniel Riggs · Greensboro, NC3 sharedAngelo F. Rufino · BOSTON, MA3 sharedJason Sanders · Greensboro, NC3 sharedDwight Bates · Greensboro, NC3 sharedDavid Spaulding · Johnston, IA2 sharedStephen Kiront · Garden City, NY2 sharedJane Taylor · TACOMA, WA2 sharedTimothy K. Chapman · North Augusta, SC2 sharedChris E. Celano · Houston, TX2 sharedMatt Ireland · TACOMA, WA2 sharedNatasha Drisdelle · Nashville, TN2 shared Recent filings (15)
Revalesio CorpDec 2025 · 20 co-filers$40.3MRevalesio CorpDec 2025 · 20 co-filers$40.3MSurgical Center of Greensboro, LLCNov 2025 · 20 co-filers$996KSurgical Center of Greensboro, LLCMar 2025 · 17 co-filers$394KTWO BEAR CAPITAL FUND II, LPJan 2025 · 4 co-filersTWO BEAR CAPITAL SPV V, LPAug 2024 · 5 co-filersSurgical Center of Greensboro, LLCJun 2024 · 24 co-filers$3.1MTWO BEAR CAPITAL SPV - IV, LPMay 2024 · 5 co-filers1200 Pharma LLCApr 2024 · 12 co-filersTORL Biotherapeutics LLCApr 2024 · 16 co-filers$158.3MRevalesio CorpApr 2024 · 22 co-filers$30.6MRevalesio CorpApr 2024 · 22 co-filers$30.6MTWO BEAR CAPITAL SEED FUND I, LPFeb 2024 · 4 co-filersTWO BEAR CAPITAL SPV III, LPDec 2023 · 5 co-filersTWO BEAR CAPITAL SPV II, LPMar 2023 · 5 co-filersSurgical Center of Greensboro, LLCDec 2022 · 14 co-filers$1.2MTWO BEAR CAPITAL SPV - IN, LPDec 2022 · 5 co-filers Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Chris in the interactive graph →